Oppenheimer & Co’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.24M | Buy |
103,270
+4,524
| +5% | +$98.2K | 0.03% | 537 |
|
2025
Q1 | $2.39M | Sell |
98,746
-5,741
| -5% | -$139K | 0.04% | 493 |
|
2024
Q4 | $2.18M | Buy |
104,487
+23,078
| +28% | +$482K | 0.03% | 513 |
|
2024
Q3 | $1.62M | Sell |
81,409
-5,314
| -6% | -$106K | 0.02% | 616 |
|
2024
Q2 | $1.34M | Buy |
86,723
+36,192
| +72% | +$561K | 0.02% | 660 |
|
2024
Q1 | $805K | Buy |
+50,531
| New | +$805K | 0.01% | 818 |
|